Clinical trial
Efficacy and Safety of Itopride vs Placebo in Heartburn
NCT00382577 · Forest Laboratories, Industry · Completed
Key facts
| NCT number | NCT00382577 |
|---|---|
| Title | Efficacy and Safety of Itopride vs Placebo in Heartburn |
| Official title | A Randomized, Double-blind, Two Period, Crossover Study to Evaluate the Effects of a Single Dose of Itopride 200 mg on Esophageal and Gastric pH and Reflux in Patients With Heartburn |
| Lead sponsor | Forest Laboratories, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Heartburn |
| Intervention type | Drug |
| Interventions | Itopride, Placebo |
| Enrollment | 48 |
| Start date | Oct 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Sep 29, 2006 |
| Last update posted | Feb 9, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: